Status:
COMPLETED
Estimation of the Incidence of Colonization of Peripheral Venous Catheters After Skin Disinfection With 0.5% Sodium Hypochlorite, Preceded or Not by an Application of 70% Ethanol
Lead Sponsor:
Poitiers University Hospital
Conditions:
Skin Disinfection Before Peripheral Venous Catheter Insertion
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The peripheral venous catheter is the most commonly used medical device in the hospital setting. Infectious complications are infrequent, bacterial or fungal, and local or systemic (catheter-related b...
Eligibility Criteria
Inclusion
- Adult patient (≥18 years old) requiring hospitalization in participating services
- Having an indication for the placement of a peripheral venous catheter for an expected duration of at least 48 hours
- Free subject, without guardianship or curatorship or subordination
- A person affiliated to or benefiting from a social security scheme.
- Having given free and informed consent
Exclusion
- Hypersensitivity to any of the constituents of Dakin® and/or Cooper® modified alcohol;
- History of epilepsy,
- Placement of a peripheral venous catheter in the emergency room that does not allow the usual rules of hygiene to be respected;
- Difficult vascular access foreseeable (drug addict, obese, non-visible veins...);
- Participation in another research protocol reducing the risk of catheter-related infection;
- Patient having received an antibiotic treatment in the 15 days prior to inclusion in the study;
- Patient who has already participated in the study;
- Subjects not affiliated with a Social Security system.
- Subjects benefiting from enhanced protection, namely persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection (guardianship and trusteeship) and finally patients in emergency situations.
- Pregnant or breastfeeding women, women of child-bearing age who do not have effective contraception (hormonal/mechanical: per os, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy...).
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 8 2021
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04391660
Start Date
June 15 2020
End Date
January 8 2021
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Poitiers
Poitiers, France, 86021